Transcript
Page 1: Beaver Dam Eye Study: Overall Participant Flow

Beaver Dam Eye Study: Overall Participant Flow

Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

Page 2: Beaver Dam Eye Study: Overall Participant Flow

Beaver Dam Eye Study: Flow of Participants From the Third Examination Who Were Eligible for

Nuclear Cataract Analyses

Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

Page 3: Beaver Dam Eye Study: Overall Participant Flow

Distribution and Age-Adjusted ORs for Each Cataract Type Based on Statin Use

Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

Page 4: Beaver Dam Eye Study: Overall Participant Flow

Characteristics at the Third Examination (1998-2000) of Participants

Who Developed Nuclear Cataract Compared With Those Who Did Not*

Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

Page 5: Beaver Dam Eye Study: Overall Participant Flow

Five-Year Incidence of Nuclear Cataract Identified at Fourth Examination, Classified

by Use of Statins at Third Examination, 1998-

2000

Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

Page 6: Beaver Dam Eye Study: Overall Participant Flow

Incident Nuclear Cataract by Duration of Statin Use*

Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758


Top Related